Skip to main content
MYGN logo

MYGN · Myriad Genetics Inc · Held by Funds

Track MYGN — free
$6.63 +0.00 (+0.00%) Q2 2026 earnings call transcript
Market Cap
$634.16M
Shares
95.65M
Volume · Oct 29 414.26K Avg daily vol (3M) 2.63M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of MYGN by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 18.16% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.36% 3,209,222
Index ETFs 14.80% 14,158,670
Active ETFs 1.53% 1,459,448
Active funds 8.46% 8,090,094
Unclassified 1.64% 1,568,342
All registered funds 29.78% 28,485,776
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding MYGN

222 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 222 positions
Key facts CIK 899923 CUSIP 62855J104 13F (30d) 25 filings 25 filers Visit website Investor relations